FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2024
Back to search
Official data from USPTO
LIPOFLUIDICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LIPOFLUIDICS
ST13
US500000079366379Class
1, 5, 40, 42
Filing
79366379
Registration
7423998
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
12/28/2024
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
02/27/2023
Registration date
06/25/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
06/25/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
82
Owner location
AU
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Spectrumceuticals Pty Ltd
Representatives
Janice Housey Litmus Law PLLC
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Liposomes for non-medical useindustrial chemicals in the nature of liposome encapsulated molecules and vitamins for use in the manufacture of pharmaceutical products and complementary medicines; vitamins for use in the manufacture of food supplements; vitamins for use in the manufacture of pharmaceuticals; mineral preparations for use in manufacturingmineral acidsminerals being sodium chloridesodium carbonate and sodium sulfatepotassium being potassium citratepotassium chloridepotassium phosphatepotassium aspartatepotassium bicarbonate and potassium gluconatecalcium being calcium carbonate and calcium citratemagnesium being magnesium aspartatemagnesium citratemagnesium oxidemagnesium chloridemagnesium lactatemagnesium malatemagnesium tauratemagnesium L-threonatemagnesium sulfatemagnesium glycinate and magnesium orotate and trace elements being iron being ferrous sulfateferrous gluconateferric citrateferric sulfatecopper being cupric oxidecupric sulfatecopper gluconatecopper amino acid chelateszinc being zinc picolinatezinc citratezinc acetatezinc glyceratezinc monomethionineseleniumiodinechromium being chromium picolinatechromium nicotinatechromium polynicotinatechromium chloridechromium histidinatmanganese being manganese sulfatemanganese gluconate and manganese chelatemolybdenum being molybdenum chloridesodium molybdatemolybdenum glycinatemolybdenum amino acid chelate; chemical products and chemical substanceschemical additivesfor use in the manufacture of medicinal and pharmaceutical preparations and substances; enzymes for scientific purposes; fats and sugars being chemical substances for medicine manufacturelipidsphospholipidscarbohydratescarbohydrate conjugates and industrial purpose sugar alcohols for use in the manufacture of medicines
Class 5
Complementary medicines including liposomal nutrientsdietary supplementsnutritional supplements and vitamin supplements; dietary supplements; dietetic food supplements adapted for medical purposes; enzyme dietary supplements; food supplements being dietary supplements; food supplements for medical purposes; medicinal herbal preparations; herbal dietary supplements; vitamins; minerals being mineral supplements; medicated preparations for use as supplements for food; mineral food supplements; mineral preparations for use as dietary supplements to drinking water; nutritional supplements; protein dietary supplements; protein supplements for humans; supplements containing trace elements for foodstuffs for human consumption; vitamin preparations in the nature of food supplements; pharmaceutical preparations in the nature of dietary supplementsnutritional supplements and medicinal herbal supplements for health care; probioticsprobiotic supplements; nutritionalmedicinal and naturopathic preparationsadjuvants for the aforementioned goodsdietary supplementsnutritional supplementsfood supplements being dietary supplementsand medicinal herbal supplements; amino acids for nutritional purposes; pharmaceutical products derived from natural sourcesdietary supplementsnutritional supplementsfood supplements being dietary supplementsand medicinal herbal supplements; edible fish oil for medical purposes; evening primrose oil for medical use; esters of fatty acids for use as pharmaceutical preparationsdietary supplementsnutritional supplements and food supplements being dietary supplementscontaining esters of fatty acids
Class 40
Custom manufacture of goods in the nature of complementary medicinestraditional medicinesdietary supplementsnutritional supplements and medicinal herbal supplements; assembly of customized materials in the nature of complementary medicinestraditional medicinesdietary supplementsnutritional supplements and medicinal herbal supplements for others; medicinal materials treatment and processing; complementary medicines materials treatment and processing; material and productcomplementary medicinestraditional medicinesdietary supplementsnutritional supplements and medicinal herbal supplements processing services; chemistry reagent processing; treatment of materials in the nature of complementary medicinestraditional medicinesdietary supplements and medicinal herbal supplements; pharmaceutical filtration services being pharmaceutical processing services; processing of biopharmaceutical materials for others; custom fabricatingmaking or manufacturing of goods or materialsmanufacture of complementary medicinestraditional medicinesdietary supplements and medicinal herbal supplements for others; advisoryconsultancy and information services in respect of all of the aforementioned services
Class 42
Research and development services in respect of complementary medicines and nanoparticle delivery systems; research services in the field of natural health; product development services in respect of complementary medicines; technical research in the field of complementary medicines studies; research and development of new products for others; science laboratory services; scientific research; quality control of complementary medicines services; quality testing services; quality assessment servicesproduct quality testing services in respect of complementary medicines and traditional medicines; chemical analysis and research services; bacteriological research services; clinical trials; medical research services; complementary medicine researchtesting and development services; packaging design; technological servicesscientific research in respect of complementary medicinesdietary supplementsmedicinal herbal supplements and nanoparticle delivery systems; industrial analysis and research services in the field of complementary medicinestraditional medicines and nanoparticle delivery systems; research and development in the field of therapeutics; researchdevelopmentscientific analysis and qualitysafety and efficacy evaluation services in connection with biotechnologymicroorganismspharmaceuticalsmedicinemicrobiomebiochemistryprobioticsprebioticsnutritional supplements; dietary supplements and nutraceutical supplements; advisoryconsultancy and information services in respect of all of the aforementioned services
Publications
History of USPTO decisions and trademark events.
31 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/10/2024
FIMP
FINAL DISPOSITION PROCESSED
12/10/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/25/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/25/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/16/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/09/2024
PUBO
PUBLISHED FOR OPPOSITION
04/09/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/27/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/27/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/20/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
03/04/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/04/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/04/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/21/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/21/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/21/2024
RFNT
REFUSAL PROCESSED BY IB
02/06/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/18/2024
RFRR
REFUSAL PROCESSED BY MPU
01/18/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/02/2023
CNRT
NON-FINAL ACTION WRITTEN
12/01/2023
DOCK
ASSIGNED TO EXAMINER
11/28/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/31/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
10/01/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/03/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/30/2023
Continuous trademark protection
Get notified about every new filing that threatens LIPOFLUIDICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.